A carregar...
Phase II Trial of Sorafenib (BAY43-9006) in Patients with Advanced Urothelial Cancer (E1804): A Trial of the Eastern Cooperative Oncology Group
BACKGROUND: There is no effective second line systemic chemotherapy for patients with disease progression following cisplatin-based chemotherapy. A phase II trial of sorafenib was performed to determine the activity and toxicity of this agent in a multiinstitutional setting in patients previously tr...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2774800/ https://ncbi.nlm.nih.gov/pubmed/19536901 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24467 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|